We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Game-changing blood test for concussions developed
News

Game-changing blood test for concussions developed

Game-changing blood test for concussions developed
News

Game-changing blood test for concussions developed

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Game-changing blood test for concussions developed"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Scientists from Children's Health Research Institute in London, Canada, a program of Lawson Health Research Institute, and Western University have developed a new blood test that identifies with greater than 90 percent certainty whether or not an adolescent athlete has suffered a concussion.


Diagnosis of a clinically significant concussion, or a mild traumatic brain injury, can be difficult as it currently relies on a combination of patient symptom assessment and clinician judgement. Equally problematic are the decisions to stop play or activities, or when patients who have suffered a concussion can safely return to normal activities without risking further injury.


See Also: Researchers identify concussion treatment for persistent cases in children


In the new study, researchers have demonstrated that a blood test can now accurately diagnose a concussion using a form of blood profiling known as metabolomics. Dr. Douglas Fraser, a physician in the Paediatric Critical Care Unit at Children's Hospital, London Health Sciences Centre and Lawson scientist, led the study with his co-investigator Mark Daley, a professor in the Departments of Computer Science, Biology and Statistics & Actuarial Sciences at Western University.


In the relatively inexpensive test, blood is drawn from an individual that may have suffered a concussion as the result of a sudden blow to the head (or from transmitted forces from a sudden blow to the body) within 72 hours of the incident. The scientists measure a panel of metabolites—small molecules that are the products of the body's metabolism—in the blood to search for distinct patterns that indicate a concussion has occurred.


"This novel approach, to use blood testing of metabolites as a diagnostic tool for concussions, was exploratory and we were extremely pleased with the robustness of our initial results," says Fraser, also an Associate Professor in Western's Departments of Paediatrics, Physiology & Pharmacology and Clinical Neurological Sciences at the Schulich School of Medicine & Dentistry. "We looked at a host of patterns and it appears that those who suffered a concussion have a very different pattern than those who have not had a concussion."


Related: Athletes may have white matter brain changes 6 months after a concussion


This new method, fully funded by the Children's Health Foundation and conducted by the Western Concussion Study Group, is unique in that previous attempts have looked unsuccessfully for a single highly accurate protein biomarker that can distinguish concussed from non-concussed adolescent patients.


In this latest successful attempt, the researchers took a different approach and investigated a full spectrum of 174 metabolites.


"We looked at all of these metabolites in concussed male adolescent patients and in non-concussed male adolescent patients and it turns out that the spectrum is really different," explains Daley, who is also Western's Associate Vice-President (Research) and a principal investigator at Western's renowned Brain & Mind Institute. "There is no one metabolite that we can put a finger on but when we looked at all of them, those profiles are different enough that we could easily distinguish concussed patients from non-concussed. In fact, with fine tuning we can now look at sets of as few as 20 to 40 specific metabolites and maintain the diagnostic accuracy level of the test over 90 percent."


Concussion is a major public health concern, often resulting in significant acute symptoms and in some individuals, long-term neurological dysfunction.


"The discovery of a blood test that can aid in concussion diagnosis is very important," says Dr. Fraser. "With further research, we anticipate that our blood test will also aid clinicians in predicting concussion outcome, as well as aid rehabilitation after concussion."


The technology is subject to a patent application filed through WORLDiscoveries®, the joint technology transfer office of Lawson and Western.


Read Next: In rats, diffuse brain damage can occur with no signs of 'concussion,' reports study in Neurosurgery


"This relatively quick and inexpensive blood test for concussion is by far the most accurate reported with tremendous potential for clinical management and commercialization," says Kirk Brown, Manager of Business Development for Lawson.


Note: Material may have been edited for length and content. For further information, please contact the cited source.


Lawson Health Research Institute   press release


Publication

Daley M et al. Metabolomics profiling of concussion in adolescent male hockey players: a novel diagnostic method. Metabolomics, Published Online October 28 2016. doi: 10.1007/s11306-016-1131-5


Advertisement